Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06675344 · ClinicalTrials.gov registry record · NA

The Apollo Device in Systemic Sclerosis for the Management of fatiguE, Raynaud Phenomenon and qualiTy of Life

A NA study of Systemic Sclerosis (SSc), sponsored by Robyn T. Domsic, MD, MPH.

Recruiting
Registry status
NA
Development phase
160
Enrollment target
4
Study locations

NCT06675344 is a NA study of Systemic Sclerosis (SSc) that is actively recruiting participants, run by Robyn T. Domsic, MD, MPH. The registered enrollment target is 160 participants, above the 82-participant average among 8 other Systemic Sclerosis (SSc) trials with a reported enrollment target (95% higher). The trial reports 4 study locations across 4 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06675344, a NA study of Systemic Sclerosis (SSc), is actively recruiting participants, sponsored by Robyn T. Domsic, MD, MPH.

RECRUITING
Registry status
NA
Development phase
160 participants
Enrollment target
4
Study locations

Study Summary

The purpose of this study it to test the efficacy of a wearable device to improve symptom management and maximize qualify of life in systemic Sclerosis (SSc) patients in a randomized trial. Specifically, we will evaluate if the Apollo Neuro device may improve the two specific symptoms highest ranked by patients as affecting qualify of life (fatigue, Raynaud phenomenon) as co-primary outcomes.

Conditions Studied

Systemic Sclerosis (SSc)

Interventions

  • DEVICE Sham device
  • DEVICE Apollo Neuro Device

Study Locations (4)

Louisiana

  • DelRicht Research Center - New Orleans

Michigan

  • University of Michigan - Ann Arbor

Pennsylvania

  • University of Pittsburgh and UPMC Scleroderma Center - Pittsburgh

Tennessee

  • Vanderbilt University Medical Center - Nashville

Trial Details

FieldValue
Enrollment Target 160 participants
Start Date 2025-01-06
Est. Completion 2028-09
Phase NA

Sponsor

Robyn T. Domsic, MD, MPH

4 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06675344

The ClinicalTrials.gov registry entry for NCT06675344 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 160 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 82-participant average among 8 other Systemic Sclerosis (SSc) trials with a reported enrollment target (95% higher). The listed sponsor is Robyn T. Domsic, MD, MPH, which has 4 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Systemic Sclerosis (SSc) appearing as the primary indexed condition, and to 2 interventions - of which Sham device is the first listed.

NCT06675344 reports 4 study locations spanning 4 distinct geographic areas - top geographies include Louisiana, Michigan, Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT06675344 about?

NCT06675344 is a clinical study titled "The Apollo Device in Systemic Sclerosis for the Management of fatiguE, Raynaud Phenomenon and qualiTy of Life". The purpose of this study it to test the efficacy of a wearable device to improve symptom management and maximize qualify of life in systemic Sclerosis (SSc) patients in a randomized trial. Specifically, we will evaluate if the Apollo Neuro device may improve the two specific symptoms highest ranked...

What is the current status of trial NCT06675344?

This trial is currently recruiting. It is a NA study. The enrollment target is 160 participants. The study started on 2025-01-06. Estimated completion is 2028-09.

What conditions does trial NCT06675344 study?

This clinical trial studies the following conditions: Systemic Sclerosis (SSc).

What interventions are being tested in trial NCT06675344?

The interventions under investigation include: Sham device (DEVICE), Apollo Neuro Device (DEVICE).

Who is sponsoring clinical trial NCT06675344?

This trial is sponsored by Robyn T. Domsic, MD, MPH, which has 4 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06675344 being conducted?

This trial has 4 study locations across Louisiana, Michigan, Pennsylvania, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Systemic Sclerosis (SSc)

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Systemic Sclerosis (SSc)

All registered trials for this condition

Louisiana

All trials with a study site in Louisiana

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.